Welcome to our dedicated page for Chemed news (Ticker: CHE), a resource for investors and traders seeking the latest updates and insights on Chemed stock.
Chemed Corp (NYSE: CHE) delivers essential services through two core divisions: VITAS Healthcare, a leader in hospice and palliative care, and Roto-Rooter, the nation's largest plumbing and drain cleaning provider. This news hub provides timely updates on corporate developments, financial performance, and operational milestones across both sectors.
Investors and industry observers will find comprehensive coverage of earnings reports, strategic acquisitions, leadership changes, and regulatory updates. The page also tracks service expansions in end-of-life care programs and infrastructure maintenance innovations, offering insights into how Chemed maintains its dual-market leadership.
All content is curated to help stakeholders monitor the company's progress in healthcare compassion and technical service reliability. Bookmark this page for direct access to press releases, analyst commentaries, and market-moving announcements from Chemed Corporation.
Chemed Corporation (NYSE:CHE) will release its second quarter financial results on July 27, 2021, after market close. The company plans to host a conference call and webcast on July 28, 2021, at 10 a.m. ET to discuss the results and provide business updates. Participants can access the call via toll-free numbers or through a live webcast on Chemed's website. The replay will be available later for one week. Chemed operates VITAS Healthcare and Roto-Rooter, with VITAS being the largest hospice care provider in the U.S.
Chemed Corporation (NYSE:CHE) will present at the Jefferies 2021 Virtual Healthcare Conference on June 2, 2021, at 11:30 a.m. (ET). The presentation will be available via live webcast, with materials accessible on the Chemed website. A replay will be available within 24 hours and can be accessed for 90 days. Chemed operates two subsidiaries: VITAS Healthcare, the largest provider of hospice care in the U.S., and Roto-Rooter, the leading plumbing and drain cleaning service provider. Forward-looking statements are made, but investors are advised of potential risks.
Chemed Corporation (NYSE:CHE) has announced a $300 million increase in its existing stock repurchase program, signaling strong confidence in its financial position. The repurchases will be funded through operational cash and a revolving credit facility, emphasizing Chemed's commitment to enhancing shareholder value. As a leader in hospice care and plumbing services via its subsidiaries, VITAS Healthcare and Roto-Rooter, this move is expected to positively impact earnings per share (EPS) and reflect robust operational cash flow.
Chemed Corporation (NYSE:CHE) held its annual stockholders’ meeting today, where a slate of 10 directors was elected for another term. Stockholders approved the continuation of PricewaterhouseCoopers LLP as independent accountants for 2021 and ratified executive compensation. Notably, a quarterly cash dividend of 34 cents per share was declared, payable on June 16, 2021, to shareholders of record as of May 27, marking Chemed's 200th consecutive quarterly dividend in its 50 years as a public company.
Chemed Corporation (NYSE:CHE) will present virtually at the RBC Capital Markets Global Healthcare Conference on May 19, 2021, at 10:20 a.m. (ET). The audio webcast will be available on the Chemed website shortly after the presentation and will remain accessible for 90 days. Chemed, headquartered in Cincinnati, operates VITAS Healthcare, the largest end-of-life hospice provider, and Roto-Rooter, a leading plumbing service. Investors should note the forward-looking statements in this release, which are subject to risks and uncertainties that could affect actual outcomes.
Chemed Corporation (NYSE:CHE) will present at the BofA Securities 2021 Virtual Health Care Conference on May 11, 2021, at 12:30 PM ET. The presentation will be webcast live on the Chemed website, with materials available for access. A replay will be available within 24 hours and can be accessed for 90 days. Chemed operates VITAS Healthcare, the largest provider of hospice care in the U.S., and Roto-Rooter, a leading plumbing and drain cleaning company. Forward-looking statements are included in the release, with caution regarding inherent risks.
Chemed Corporation (NYSE: CHE) reported Q1 2021 financial results, showing a 2.2% revenue increase to $527 million. GAAP EPS rose 18.6% to $4.01, with adjusted EPS up 20.7% to $4.44. However, VITAS Healthcare saw a 6.5% decline in net patient revenue to $316 million, impacted by lower census and admissions. Contrastingly, Roto-Rooter experienced 18.9% revenue growth to $212 million, driven by a 32% increase in residential plumbing services. The company has $210 million in cash, no debt, and plans to update 2021 earnings guidance in July.
Chemed Corporation (NYSE:CHE) will release its financial results for Q1 2021 on April 27, 2021, after the market closes. A conference call is scheduled for April 28, 2021, at 10 a.m. ET to discuss these results and provide business updates. Investors can join via a toll-free number or through a live webcast on Chemed's website. The company operates two subsidiaries, VITAS Healthcare, the largest hospice care provider, and Roto-Rooter, the leading plumbing service in the U.S.
Chemed Corporation (NYSE:CHE) will present virtually at the Oppenheimer 31st Annual Healthcare Conference on March 17, 2021, at 8:40 a.m. ET. The presentation will be accessible live via the Chemed website, with materials available for download. A replay of the webcast will be available within 24 hours and remain accessible for 90 days. Headquartered in Cincinnati, Ohio, Chemed operates VITAS Healthcare, the largest provider of hospice care, and Roto-Rooter, the leading plumbing service in the U.S.
Chemed Corporation reported its fourth-quarter 2020 financial results, indicating a 2.1% revenue increase to $533 million. GAAP diluted EPS rose to $6.96, a 75.8% increase. The VITAS segment faced a 2.3% decline in net patient revenue, totaling $332 million, with admissions increasing by 2.8%. In contrast, Roto-Rooter reported a 10.2% revenue rise to $201 million. The company anticipates VITAS revenue to drop by 4.0% in 2021, while Roto-Rooter expects 5%-6% growth. Chemed had $163 million in cash and no long-term debt.